Refractive Surgery News

A study conducted in the United Kingdom found “excellent” outcomes for Presbyond laser blended vision LASIK in pilots requiring Class 1 certification.

Johnson & Johnson Vision received CE mark approval for the Elita femtosecond laser system, which corrects myopia in patients with or without astigmatism through the SILK procedure, according to a press release.

TAMPA, Fla. — In this Healio Video Perspective from the Telling It Like It Is meeting, Neda Shamie, MD, talks about why it is important to offer the EVO ICL to refractive patients, as well as proper lens sizing.

In this Healio Video Perspective from the EnVision Summit, P. Dee Stephenson, MD, FACS, explains how current femtosecond laser options provide surgeons with effective tools to address a variety of complex cases.

The Least Absolute Shrinkage and Selection Operator formulas, or LASSO, showed “excellent” performance for predicting ICL vault after implantation.

We now have more than a year’s worth of experience with Vuity, the first pharmaceutical FDA approved for the treatment of age-related blurry vision or presbyopia.

Even small amounts of astigmatism reduce patients’ postoperative quality of uncorrected vision and satisfaction after refractive cataract surgery.

Vuity has been available for more than a year, in which time we have learned a lot about this modality for treating presbyopia and honed our methods for selecting, screening and educating patients.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Neda Nikpoor, MD, discusses the benefits that the EVO ICL can provide to patients for vision correction, including those with lower levels of myopia.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Karl G. Stonecipher, MD, discusses enhancement strategies for cataract surgery.